HPV virions hitchhike a ride on retromer complexes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 18, 2013, Pages 7116-7117

  Sapp, Martin J ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CAPSID PROTEIN L1; CAPSID PROTEIN L2; RAB PROTEIN; UNCLASSIFIED DRUG;

CONDYLOMA ACUMINATUM; CYTOPLASM; ENDOPLASMIC RETICULUM; NONHUMAN; NOTE; PAPILLOMA; PRIORITY JOURNAL; VIRION; VIRUS ENTRY; VIRUS PARTICLE; WART VIRUS;

GENOME, HUMAN; HUMANS; PAPILLOMAVIRIDAE; RNA INTERFERENCE; RNA, SMALL INTERFERING; VESICULAR TRANSPORT PROTEINS; VIRUS INTERNALIZATION;

HUMAN PAPILLOMAVIRUS;

EID: 84876901328     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1305245110     Document Type: Note

References (20)

1. Lipovsky A, et al. (2013) Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc Natl Acad Sci USA 110:7452-7457.
2. Crow JM (2011) HPV: The global burden. Nature 488(7413):S2-S3.
3. Bienkowska-Haba M, Patel HD, Sapp M (2009) Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog 5(7):e1000524.
4. Dasgupta J, et al. (2011) Structural basis of oligosaccharide receptor recognition by human papillomavirus. J Biol Chem 286(4):2617-2624.
5. Day PM, et al. (2007) Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol 81(16):8784-8792. (Pubitemid 47242851)
6. Richards RM, Lowy DR, Schiller JT, Day PM (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci USA 103(5):1522-1527. (Pubitemid 43191198)
7. Scheffer KD, et al. (2013) Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J Virol 87(6):3435-3446.
8. Schelhaas M, et al. (2012) Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog 8(4):e1002657.
9. Surviladze Z, Sterk RT, DeHaro SA, Ozbun MA (2013) Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy. J Virol 87(5):2508-2517.
10. Bienkowska-Haba M, Williams C, Kim SM, Garcea RL, Sapp M (2012) Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry. J Virol 86(18):9875-9887.
11. Selinka HC, Giroglou T, Sapp M (2002) Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 299(2):279-287. (Pubitemid 35356605)
12. Schneider MA, Spoden GA, Florin L, Lambert C (2011) Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol 13(1):32-46.
13. Cullen PJ, Korswagen HC (2012) Sorting nexins provide diversity for retromer-dependent trafficking events. Nat Cell Biol 14(1):29-37.
14. Day PM, Thompson CD, Schowalter RM, Lowy DR, Schiller JT (2013) Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus Infection. J Virol 87(7):3862-3870.
15. Bronnimann MP, Chapman JA, Park CK, Campos SK (2013) A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection. J Virol 87(1):464-473.
16. Kämper N, et al. (2006) A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 80(2):759-768. (Pubitemid 43062888)
17. Bergant M, Banks L (2013) SNX17 facilitates infection with diverse papillomavirus types. J Virol 87(2):1270-1273.
18. Bossis I, et al. (2005) Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection. J Virol 79(11):6723-6731. (Pubitemid 40677303)
19. Kartenbeck J, Stukenbrok H, Helenius A (1989) Endocytosis of simian virus 40 into the endoplasmic reticulum. J Cell Biol 109(6 Pt 1):2721-2729. (Pubitemid 20011899)
20. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF (2009) Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5(2):e1000318.